LianBio
LIANY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831283
No open-market purchases or sales by LianBio insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in LianBio as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- 0 vs. Q2 2022
- Shares held
- 84.0M
- −2.57M (−3.0%) vs. Q2 2022
- Total value
- $168.0M
- −$19.1M (−10.2%) vs. Q2 2022
- New holders
- 6
- 18 more added
- Sold out
- 6
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LIANY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $1.00K |
| Q1 2026 | 1 | $1.00K |
| Q4 2025 | 1 | $1.00K |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $5.00K |
| Q1 2025 | 1 | $2.00K |
| Q4 2024 | 2 | $42.1K |
| Q3 2024 | 2 | $47.3K |
| Q2 2024 | 2 | $50.5K |
| Q1 2024 | 3 | $49.2K |
| Q4 2023 | 29 | $377.3M |
| Q3 2023 | 38 | $117.7M |
| Q2 2023 | 39 | $182.9M |
| Q1 2023 | 36 | $157.1M |
| Q4 2022 | 40 | $133.3M |
| Q3 2022 | 44 | $168.0M |
| Q2 2022 | 44 | $187.1M |
| Q1 2022 | 37 | $318.6M |
| Q4 2021 | 36 | $550.5M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding LianBio; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 178 | $0 | 0.00% | +178 | New |
| UBS Group AG | 1,247 | $2.00K | 0.00% | +1,247 | New |
| Bank of America Corp | 8,177 | $16.0K | 0.00% | +7,174+715.3% | Added |
| Commonwealth Equity Services, LLC | 10,830 | $21.0K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 10,650 | $21.0K | 0.00% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 11,500 | $23.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 12,157 | $24.0K | 0.00% | +12,157 | New |
| Bailard, Inc. | 19,606 | $39.0K | 0.00% | −27,991−58.8% | Reduced |
| Tower Research Capital LLC (TRC) | 20,773 | $41.0K | 0.00% | +19,616+1,695.4% | Added |
| Susquehanna International Group, LLP | 23,245 | $46.0K | 0.00% | +23,245 | New |
| Vident Investment Advisory, LLC | 28,616 | $57.0K | 0.00% | +8,703+43.7% | Added |
| Powell Investment Advisors, LLC | 30,000 | $60.0K | 0.04% | +30,000 | New |
| Old Well Partners, LLC | 32,200 | $64.0K | 0.05% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 39,000 | $78.0K | 0.00% | +20,100+106.3% | Added |
| Morgan Stanley | 55,146 | $110.0K | 0.00% | +54,145+5,409.1% | Added |
| Alps Advisors Inc | 58,490 | $116.0K | 0.00% | −5,738−8.9% | Reduced |
| Thrivent Financial for Lutherans | 80,959 | $162.0K | 0.00% | +1,739+2.2% | Added |
| Cornercap Investment Counsel Inc | 81,830 | $163.0K | 0.03% | +29,690+56.9% | Added |
| Manufacturers Life Insurance Company, The | 117,484 | $236.1K | 0.00% | +39,700+51.0% | Added |
| MYDA Advisors LLC | 120,000 | $240.0K | 0.13% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 125,972 | $252.0K | 0.03% | +29,388+30.4% | Added |
| 22NW, LP | 141,223 | $282.0K | 0.16% | 00.0% | Unchanged |
| Victory Capital Management Inc | 173,460 | $347.0K | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 178,519 | $359.0K | 0.00% | +23,600+15.2% | Added |
| Marshall Wace, LLP | 206,497 | $410.0K | 0.00% | −16,894−7.6% | Reduced |
| Casdin Capital, LLC | 206,415 | $411.0K | 0.03% | 00.0% | Unchanged |
| Millennium Management LLC | 210,390 | $419.0K | 0.00% | +97,189+85.9% | Added |
| Barclays PLC | 268,400 | $537.0K | 0.00% | +268,400 | New |
| Logos Global Management LP | 307,908 | $616.0K | 0.08% | −86,578−21.9% | Reduced |
| Renaissance Technologies LLC | 315,000 | $630.0K | 0.00% | +254,100+417.2% | Added |
| Alyeska Investment Group, L.P. | 429,186 | $858.0K | 0.01% | +100,000+30.4% | Added |
| Affinity Asset Advisors, LLC | 550,000 | $1.09M | 0.50% | +100,000+22.2% | Added |
| Citigroup Inc | 707,336 | $1.41M | 0.00% | +258,817+57.7% | Added |
| Hudson Bay Capital Management LP | 713,743 | $1.42M | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 840,169 | $1.67M | 0.00% | +2,996+0.4% | Added |
| SCHF (Gpe), LLC | 937,500 | $1.88M | 2.47% | 00.0% | Unchanged |
| BlackRock Inc. | 1,023,107 | $2.05M | 0.00% | −8,976−0.9% | Reduced |
| Wellington Management Group LLP | 1,032,084 | $2.05M | 0.00% | 00.0% | Unchanged |
| Vida Ventures Advisors, LLC | 2,282,084 | $4.56M | 4.10% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,822,857 | $5.62M | 0.00% | +695,979+32.7% | Added |
| Tybourne Capital Management (HK) Ltd | 3,303,573 | $6.61M | 0.64% | −10,600−0.3% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,564,173 | $7.09M | 0.03% | 00.0% | Unchanged |
| VR Adviser, LLC | 5,378,341 | $10.8M | 1.66% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 57,558,451 | $115.1M | 3.35% | +998,240+1.8% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −4,622,574−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −315,191−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −32,300−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,740−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −11,900−100.0% | Sold out |